Pentadecanoic and Heptadecanoic Acids: Multifaceted Odd-Chain Fatty Acids.

The odd-chain fatty acids (OCFAs) pentadecanoic acid (15:0) and heptadecanoic acid (17:0), which account for only a small proportion of total saturated fatty acids in milk fat and ruminant meat, are accepted biomarkers of dairy fat intake. However, they can also be synthesized endogenously, for example, from gut-derived propionic acid (3:0). A number of studies have shown an inverse association between OCFA concentrations in human plasma phospholipids or RBCs and risk of type 2 diabetes and cardiovascular disease. We propose a possible involvement in metabolic regulation from the assumption that there is a link between 15:0 and 17:0 and the metabolism of other short-chain, medium-chain, and longer-chain OCFAs. The OCFAs 15:0 and 17:0 can be elongated to very-long-chain FAs (VLCFAs) such as tricosanoic acid (23:0) and pentacosanoic acid (25:0) in glycosphingolipids, particularly found in brain tissue, or can be derived from these VLCFAs. Their chains can be shortened, yielding propionyl-coenzyme A (CoA). Propionyl-CoA, by succinyl-CoA, can replenish the citric acid cycle (CAC) with anaplerotic intermediates and, thus, improve mitochondrial energy metabolism. Mitochondrial function is compromised in a number of disorders and may be impaired with increasing age. Optimizing anaplerotic intermediate availability for the CAC may help to cope with demands in times of increased metabolic stress and with aging. OCFAs may serve as substrates for synthesis of both odd-numbered VLCFAs and propionyl-CoA or store away excess propionic acid.

[1]  J. Rieusset,et al.  Contribution of mitochondria and endoplasmic reticulum dysfunction in insulin resistance: Distinct or interrelated roles? , 2015, Diabetes & metabolism.

[2]  J. Vockley,et al.  Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart review. , 2015, Molecular genetics and metabolism.

[3]  M. Blaut,et al.  Effects of dietary inulin on bacterial growth, short-chain fatty acid production and hepatic lipid metabolism in gnotobiotic mice. , 2015, The Journal of nutritional biochemistry.

[4]  J. Klein,et al.  Reduced severity of ischemic stroke and improvement of mitochondrial function after dietary treatment with the anaplerotic substance triheptanoin , 2015, Neuroscience.

[5]  R. Frye,et al.  Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome , 2015, Microbial ecology in health and disease.

[6]  W. Ratnayake,et al.  Concerns about the use of 15:0, 17:0, and trans-16:1n-7 as biomarkers of dairy fat intake in recent observational studies that suggest beneficial effects of dairy food on incidence of diabetes and stroke. , 2015, The American journal of clinical nutrition.

[7]  T. Baars,et al.  Fatty acid profiles and antioxidants of organic and conventional milk from low- and high-input systems during outdoor period. , 2015, Journal of the science of food and agriculture.

[8]  A. Koulman,et al.  A Review of Odd-Chain Fatty Acid Metabolism and the Role of Pentadecanoic Acid (C15:0) and Heptadecanoic Acid (C17:0) in Health and Disease , 2015, Molecules.

[9]  R. Crescenzo,et al.  Mitochondrial efficiency and insulin resistance , 2015, Front. Physiol..

[10]  N. Turner,et al.  Mitochondrial dysfunction and insulin resistance: an update , 2014, Endocrine connections.

[11]  M. Rewers,et al.  Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders. , 2014, The American journal of clinical nutrition.

[12]  D. Mozaffarian,et al.  Circulating biomarkers of dairy fat and risk of incident stroke in U.S. men and women in 2 large prospective cohorts. , 2014, The American journal of clinical nutrition.

[13]  R. Golley,et al.  Evaluation of the Relative Concentration of Serum Fatty Acids C14:0, C15:0 and C17:0 as Markers of Children's Dairy Fat Intake , 2014, Annals of Nutrition and Metabolism.

[14]  A. Kihara,et al.  Identification of the phytosphingosine metabolic pathway leading to odd-numbered fatty acids , 2014, Nature Communications.

[15]  Min Jung Park,et al.  Anaplerotic Triheptanoin Diet Enhances Mitochondrial Substrate Use to Remodel the Metabolome and Improve Lifespan, Motor Function, and Sociability in MeCP2-Null Mice , 2014, PloS one.

[16]  Albert Koulman,et al.  Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study , 2014, The lancet. Diabetes & endocrinology.

[17]  R. Calvani,et al.  The interplay between autophagy and mitochondrial dysfunction in oxidative stress-induced cardiac aging and pathology. , 2014, Journal of molecular and cellular cardiology.

[18]  H. Eyles,et al.  Plasma and erythrocyte fatty acids reflect intakes of saturated and n-6 PUFA within a similar time frame. , 2014, The Journal of nutrition.

[19]  A. Csiszar,et al.  Mitochondria in Cardiovascular Physiology and Disease Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease : from mechanisms to therapeutics , 2013 .

[20]  D. Mozaffarian,et al.  Biomarkers of Dairy Fatty Acids and Risk of Cardiovascular Disease in the Multi‐Ethnic Study of Atherosclerosis , 2013, Journal of the American Heart Association.

[21]  D. Mozaffarian,et al.  trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2013, The American journal of clinical nutrition.

[22]  J. Kanda,et al.  Comparison of catabolism rate of fatty acids to carbon dioxide in mice , 2012 .

[23]  E. Riboli,et al.  Plasma Phospholipid Fatty Acid Concentration and Incident Coronary Heart Disease in Men and Women: The EPIC-Norfolk Prospective Study , 2012, PLoS medicine.

[24]  M. Wajner,et al.  Disruption of mitochondrial homeostasis in organic acidurias: insights from human and animal studies , 2011, Journal of bioenergetics and biomembranes.

[25]  M. Schulze,et al.  Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2011, The American journal of clinical nutrition.

[26]  M. Peppelenbosch,et al.  Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. , 2010, Biochimica et biophysica acta.

[27]  S. Sharp,et al.  Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. , 2010, The American journal of clinical nutrition.

[28]  G. Hallmans,et al.  Biomarkers of milk fat and the risk of myocardial infarction in men and women: a prospective, matched case-control study. , 2010, The American journal of clinical nutrition.

[29]  H. Hama Fatty acid 2-Hydroxylation in mammalian sphingolipid biology. , 2010, Biochimica et biophysica acta.

[30]  L. Hellgren Phytanic acid—an overlooked bioactive fatty acid in dairy fat? , 2010, Annals of the New York Academy of Sciences.

[31]  J. Griffin,et al.  Metabolic phenotyping of a model of adipocyte differentiation. , 2009, Physiological genomics.

[32]  A. Folsom,et al.  Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. , 2008, American heart journal.

[33]  L. Weinehall,et al.  Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[34]  A. Roddam,et al.  Phytanic acid: measurement of plasma concentrations by gas–liquid chromatography–mass spectrometry analysis and associations with diet and other plasma fatty acids , 2008, British Journal of Nutrition.

[35]  I. Elmadfa,et al.  Very Low n–3 Long-Chain Polyunsaturated Fatty Acid Status in Austrian Vegetarians and Vegans , 2008, Annals of Nutrition and Metabolism.

[36]  N. Gotoh,et al.  Metabolism of odd-numbered fatty acids and even-numbered fatty acids in mouse. , 2008, Journal of oleo science.

[37]  F. Hu,et al.  Plasma and erythrocyte biomarkers of dairy fat intake and risk of ischemic heart disease. , 2007, The American journal of clinical nutrition.

[38]  D. English,et al.  Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. , 2007, The American journal of clinical nutrition.

[39]  A. Beynen,et al.  Effect of dietary fat type on meat quality and fatty acid composition of various tissues in growing-finishing swine. , 2007, Meat science.

[40]  N. Radin,et al.  Metabolism of brain glycolipid fatty acids , 2007, Lipids.

[41]  R. Rodenburg,et al.  Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. , 2006, The Biochemical journal.

[42]  R. Dahiya,et al.  Distribution of glycosphingolipids and ceramide of rat small intestinal mucosa , 1986, Lipids.

[43]  L. Weinehall,et al.  Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case–control study , 2004, British Journal of Nutrition.

[44]  C. Roe,et al.  Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. , 2002, The Journal of clinical investigation.

[45]  T. Suormala,et al.  Odd-numbered long-chain fatty acids in propionic acidaemia , 2000, European Journal of Pediatrics.

[46]  J. I. Pedersen,et al.  Peroxisomal oxidation of the steroid side chain in bile acid formation. , 1993, Biochimie.

[47]  J. I. Pedersen,et al.  Metabolic aspects of peroxisomal β-oxidation , 1991 .

[48]  J. I. Pedersen,et al.  Metabolic aspects of peroxisomal beta-oxidation. , 1991, Biochimica et biophysica acta.

[49]  G. Donnell,et al.  Propionate metabolism by cultured skin fibroblasts from normal individuals and patients with methylmalonicaciduria and propionicacidemia. , 1981, Biochemical medicine.

[50]  D. Steinberg,et al.  Identification of propionate as a degradation product of phytanic acid oxidation in rat and human tissues. , 1973, The Journal of biological chemistry.

[51]  H. Moser,et al.  Branched-chain and odd-numbered fatty acids and aldehydes in the nervous system of a patient with deranged vitamin B 12 metabolism. , 1973, Journal of lipid research.

[52]  S. Ställberg-Stenhagen,et al.  Changes in the fatty acid composition of cerebrosides and sulfatides of human nervous tissue with age. , 1968, Journal of lipid research.

[53]  J. Dodge,et al.  Composition of phospholipids and of phospholipid fatty acids of human plasma. , 1967, Journal of lipid research.

[54]  N. Radin,et al.  Biosynthesis of the cerebroside odd-numbered fatty acids , 1962 .

[55]  N. Radin,et al.  Composition of cerebroside acids as a function of age , 1959 .